Marizomib and Impurities
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Marizomib (Salinosporamide A)-d4 REF: 4Z-M-141002CAS: 437742-34-2 | - - - | To inquire | Wed 12 Jun 24 |
| Marizomib (Salinosporamide A) REF: 4Z-M-141001CAS: 437742-34-2 | - - - | To inquire | Wed 12 Jun 24 |
 | Marizomib REF: TM-T16012CAS: 437742-34-2 | 98.03% | To inquire | Wed 04 Sep 24 |
Marizomib (Salinosporamide A)-d4
CAS:437742-34-2
Formula:
C15H16ClNO4D4
Color and Shape:
Pale Yellow Solid
Molecular weight:
317.81
Ref: 4Z-M-141002
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 12 Jun 2024
Ref: 4Z-M-141001
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 12 Jun 2024
Marizomib
CAS:437742-34-2
Marizomib (ML858) is a novel irreversible brain-permeable proteasome inhibitor that inhibits CT-L (β5), CT-T-laspase-like (C-L, …
Formula:
C15H20ClNO4
Purity:
98.03%
Color and Shape:
Solid
Molecular weight:
313.78
Ref: TM-T16012
| 1mg | 641.00 € | |
| 5mg | 1,356.00 € | |
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Sep 2024
